✦ LIBER ✦

Low incidence of cardiac events in an EORTC phase II study of CMF in combination with trastuzumab in women with HER-2 positive metastatic breast cancer

✍ Scribed by D. Cameron; Marreaud; Z. Neskovic-Konstantinovic; S. Omar; M. Nooij; B. De Valk; J. Bogaerts; P. Therasse

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of bevacizumab in combi

✍ Lin, N. U.; Seah, D. S.; Gelman, R.; Desantis, S.; Mayer, E. L.; Isakoff, S.; Di 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 258 KB

A Phase II study of bevacizumab in combi

✍ Zhao, Meng; Pan, Xueliang; Layman, Rachel; Lustberg, Maryam B.; Mrozek, Ewa; Mac 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 403 KB

2122 POSTER Efficacy of combined Trastuz

✍ Z. Neskovic-Konstantinovic; M. Nooij; H. Khaled; B. De Valk; J. Vermorken; M. We 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

A Phase II Study of Weekly Vinorelbine a

✍ Juan Lucas Bayo-Calero; José I. Mayordomo; Pedro Sánchez-Rovira; Ramón Pérez-Car 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 97 KB

A phase 1 study of vinflunine in combina

✍ R. Paridaens, O. Rixe, M. C. Pinel, H. Wildiers… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 298 KB

Phase II Trial of Gemcitabine/Carboplati

✍ David Loesch; Lina Asmar; Kristi McIntyre; Lisa Doane; Michael Monticelli; Devch 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 132 KB